Egyptian International Pharmaceutical Industries Company (PHAR.CA)

Also known as:  EIPICO
Data delayed by 15 minutes
40.80 EGP 0.000.00%
As of 25 JAN 2021 - GMT|Egypt SE

EIPICO Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
8.968%
P/E (Last 12 Month)
8.315
Upside
-
Target Price (Mean)
-
52Wk
40.1 20 JAN
44.6 05 JAN

Open
Data not available
Previous Close
40.80 EGP
Turnover
Data not available
EPS
4.907 EGP
Volume
0
Transactions
0
Market Cap
4.05B EGP
IPO Date
27-Sep-1995
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Egyptian International Pharmaceutical Industries CompanyLast updated on: 28 February 2018

Business Summary
Manufacture of generic drugs, veterinary, cosmetics and skin care, vitamins and nutritional products. Through its main subsidiaries; it manufactures ampoules, detergents and insecticides.
Country of Incorporation
Ownership Type
Established In
1980
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
PHAR.CASEOrdinaryEGPEgypt SEPHAR

Contact details

Primary address
Building: Egyptian International Pharmaceutical Industries Company Building
Street: Othman Ibn Afan Street
Area: Industrial Zone B1
P.O. Box: 149
Country: Egypt
City: 10th of Ramadan
City Suffix: 44629
CONTACT
Region
Sharqia
More

India's rise as the 'world's pharmacy'

Both the UAE and India were exemplary in controlling the spread of the pandemic with the critical help of the frontline healthcare staff

Khaleej Times - Tuesday 26 January 2021

EU seeks supply answers from AstraZeneca

The European Union wants swift action to be taken by drugmaker AstraZeneca to find a solution to supply issues of COVID-19 vaccine to the bloc, after it was announced there would be a massive shortfall during the first quarter of the year. Adam Reed reports.

Reuters Videos - Monday 25 January 2021
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Dr Ahmad Borhan El Din Ismail
Managing Director and General Manager
Mr Ali Ibrahim Ragheb
Finance Director
Dr Mohammed Farouk Esmat
Export Director

Board Members

Dr Ahmad Borhan El Din Ismail
Chairman
Dr Jamal Salaheddine Mahmoud Awad
Director representing Arab Company for Drug Industries & Medical Appliances
Dr Tamer Mohammed Issam Youssef Ezeddine
Director representing Arab Company for Drug Industries & Medical Appliances
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
MEDICAL PACK0.798 EGP0.00
CLEOPATRA HOSP4.790 EGP0.00
CAIRO PHARMAC.36.030 EGP0.00
MINAPHARM PHARMA86.430 EGP0.00
ALX. PHARMACEUT.136.020 EGP0.00
More
More

Most Viewed Stocks

Stock Screener

More